Example: Heart Attack

Clinical Trials on Congenital Myotonic Dystrophy

Total 6 results

    • NCT03692312
      Not yet recruiting
      Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
      Conditions: Congenital Myotonic Dystrophy
    • NCT03059264
      Suspended
      Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy
      Conditions: Congenital Myotonic Dystrophy
    • NCT02398786
      Recruiting
      Myotonic Dystrophy Family Registry
      Conditions: Myotonic Dystrophy; Congenital Myotonic Dystrophy; Myotonic Dystrophy 1; Myotonic Dystrophy 2; Dystrophia Myotonica; Dystrophia Myotonica 1; Dystrophia Myotonica 2; Myotonia Dystrophica; Myotonic Dystrophy, Congenital; Myotonic Myopathy, Proximal; PROMM (Proximal Myotonic Myopathy); Proximal Myotonic Myopathy; Steinert Disease; Steinert Myotonic Dystrophy; Steinert's Disease; Myotonia Atrophica
    • NCT00082108
      Recruiting
      Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
      Conditions: Myotonic Dystrophy; Facioscapulohumeral Muscular Dystrophy; Muscular Dystrophy; Myotonic Dystrophy Type 1; Myotonic Dystrophy Type 2; Congenital Myotonic Dystrophy; PROMM (Proximal Myotonic Myopathy); Steinert's Disease; Myotonic Muscular Dystrophy
    • NCT02251457
      Completed
      Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
      Conditions: Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1
    • NCT02858908
      Completed
      Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy
      Conditions: Myotonic Dystrophy 1
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations